- Home
- ACIW vs APGE Comparison
ACIW vs APGE Comparison
Compare ACIW & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACIW | APGE |
|---|---|---|
| Founded | 1975 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.5B |
| IPO Year | 1996 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ACIW | APGE |
|---|---|---|
| Price | $40.87 | $68.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $62.50 | ★ $103.33 |
| AVG Volume (30 Days) | 791.4K | ★ 1.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 70.54 | 1.79 |
| EPS | ★ 1.54 | N/A |
| Revenue | ★ $1,009,780,000.00 | N/A |
| Revenue This Year | $11.52 | N/A |
| Revenue Next Year | $6.92 | N/A |
| P/E Ratio | $26.44 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $38.53 | $26.20 |
| 52 Week High | $58.14 | $84.56 |
Technical Indicators
Market Signals| Indicator | ACIW | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 43.44 | 48.70 |
| Support Level | $40.20 | $66.00 |
| Resistance Level | $41.20 | $70.57 |
| Average True Range (ATR) | 1.53 | 3.82 |
| MACD | 0.09 | 0.65 |
| Stochastic Oscillator | 42.81 | 82.23 |
Price Performance
Historical ComparisonAbout ACIW ACI Worldwide Inc.
ACI Worldwide Inc develops, markets and installs a portfolio of software products focused on facilitating electronic payments. The firm also leverages its distribution network in the Americas; Europe, the Middle East, and Africa, or EMEA; and Asia-Pacific regions to sell software developed by third parties. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but majority of the revenue is generated in the United States and EMEA regions.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.